Cargando…

Non-persistence to antihypertensive drug therapy in Lithuania

PURPOSE: Poor persistence to antihypertensive therapy is an important cause of treatment failure. Investigating persistence is especially important in countries with a high cardiovascular mortality, like Lithuania. The aim of this study was to describe the antihypertensive treatment at initiation, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Treciokiene, Indre, Bratcikoviene, Nomeda, Gulbinovic, Jolanta, Wettermark, Bjorn, Taxis, Katja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Pharmacoepidemiology and Prescription
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482566/ https://www.ncbi.nlm.nih.gov/pubmed/35918539 http://dx.doi.org/10.1007/s00228-022-03369-0

Ejemplares similares

Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study
por: Eriksson, Irene, et al.
Publicado: (2017)

Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs
por: Rydberg, Diana M, et al.
Publicado: (2018)

The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations
por: Eriksson, Irene, et al.
Publicado: (2018)

Hypertension management and drug-related problems. A case report of the 23-year history of Mr. Jonas
por: Treciokiene, Indre, et al.
Publicado: (2023)

Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs
por: Komen, Joris, et al.
Publicado: (2017)

Survival of esophageal and gastric cancer patients with adjuvant and palliative chemotherapy—a retrospective analysis of a register-based patient cohort
por: Ekheden, Isabella, et al.
Publicado: (2020)

Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden
por: Frisk, P., et al.
Publicado: (2018)

A survey about label enhancement methods for parenteral medication in European hospital pharmacies
por: Larmené-Beld, K. H. M., et al.
Publicado: (2020)

Relationship between drug burden and physical and cognitive functions in a sample of nursing home patients with dementia
por: Sanders, L. M. J., et al.
Publicado: (2017)

Prevalence of suboptimal drug treatment in patients with and without multidose drug dispensing—a cross-sectional study
por: Belfrage, Björn, et al.
Publicado: (2014)

Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission
por: Seiberth, Sarah, et al.
Publicado: (2020)

Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study
por: Hedna, Khedidja, et al.
Publicado: (2015)

Number of drugs in the medication list as an indicator of prescribing quality: a validation study of polypharmacy indicators in older hip fracture patients
por: Belfrage, Björn, et al.
Publicado: (2015)

Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area
por: Grundmark, Birgitta, et al.
Publicado: (2014)

Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients
por: Holm, Johan, et al.
Publicado: (2020)

Trends and variations in the prescribing of secondary preventative cardiovascular therapies for non-ST elevation myocardial infarction (NSTEMI) in Malaysia
por: Venkatason, Padmaa, et al.
Publicado: (2018)

Drug use in pregnant women—a pilot study of the coherence between reported use of drugs and presence of drugs in plasma
por: Wolgast, Emelie, et al.
Publicado: (2017)

Clinically relevant drug–drug interactions among elderly people with dementia
por: Sönnerstam, Eva, et al.
Publicado: (2018)

Use of rivaroxaban in Germany: a database drug utilization study of a drug started in hospital
por: Jobski, Kathrin, et al.
Publicado: (2014)

A 1-year cross-sectional analysis of non-interventional post-marketing study protocols submitted to the German Federal Institute for Drugs and Medical Devices (BfArM)
por: von Jeinsen, Beatrice K. J. G., et al.
Publicado: (2013)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study
por: Reppe, Linda Amundstuen, et al.
Publicado: (2014)

Are multidose drug dispensing systems initiated for the appropriate patients?
por: Mertens, Bram J., et al.
Publicado: (2018)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Systematic review of safety in paediatric drug trials published in 2007
por: Nor Aripin, Khairun Nain Bin, et al.
Publicado: (2011)

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children
por: ter Horst, P. G. J., et al.
Publicado: (2012)

Recognition of adverse drug events in older hospitalized medical patients
por: Klopotowska, Joanna E., et al.
Publicado: (2012)

Trends in inpatient antiparkinson drug use in the USA, 2001–2012
por: Crispo, James A. G., et al.
Publicado: (2015)

Aggregation and analysis of indication-symptom relationships for drugs approved in the USA
por: Punyala, Ananth, et al.
Publicado: (2020)

Number of medications and adverse drug events by unintentional poisoning among older adults in consideration of inappropriate drug use: a Swedish population-based matched case-control study
por: Rausch, Christian, et al.
Publicado: (2017)

Drug utilisation in neonatal units in England and Wales: a national cohort study
por: Al-Turkait, Asma, et al.
Publicado: (2022)

Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities?
por: De Francia, Silvia, et al.
Publicado: (2022)

Outcomes of off-label drug uses in hospitals: a multicentric prospective study
por: Danés, I., et al.
Publicado: (2014)

Drug interaction alerts in older primary care patients, and related medically justified actions
por: Tukukino, Carina, et al.
Publicado: (2022)

Regulatory scientific advice in drug development: does company size make a difference?
por: Putzeist, Michelle, et al.
Publicado: (2010)

Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?
por: Grimmsmann, Thomas, et al.
Publicado: (2011)

Do medical students copy the drug treatment choices of their teachers or do they think for themselves?
por: Tichelaar, J., et al.
Publicado: (2009)

The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany
por: Grimmsmann, Thomas, et al.
Publicado: (2020)

Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department
por: Kauppila, Mirjam, et al.
Publicado: (2020)

The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions
por: Reumerman, M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nmmv4jlm6s00k6i6mgflbae9nq